Editas Medicine (EDIT) Other Non-Current Assets (2015 - 2025)

Editas Medicine (EDIT) has 11 years of Other Non-Current Assets data on file, last reported at $3.0 million in Q4 2025.

• On a quarterly basis, Other Non-Current Assets fell 43.02% year-over-year to $3.0 million in Q4 2025; TTM through Dec 2025 was $3.0 million, a 43.02% decrease from a year earlier, with the FY2025 full-year figure at $3.0 million, down 43.02% from the prior year.
• Other Non-Current Assets for Q4 2025 stood at $3.0 million, roughly flat from $3.0 million in the prior quarter.
• Over the last five years, Other Non-Current Assets for EDIT reached as high as $9.5 million in Q1 2024 and fell as low as $3.0 million in Q4 2025.
• Historically, Other Non-Current Assets has averaged $6.2 million across 5 years, with a median of $6.7 million in 2021.
• Across the five-year window, Other Non-Current Assets jumped 179.72% in 2021 and plunged 55.75% in 2025, its largest moves.
• Year by year, Other Non-Current Assets stood at $6.8 million in 2021, then fell by 22.87% to $5.3 million in 2022, then jumped by 63.49% to $8.6 million in 2023, then tumbled by 39.18% to $5.2 million in 2024, then plunged by 43.02% to $3.0 million in 2025.
• Per Business Quant data, the three most recent Other Non-Current Assets figures were $3.0 million in Q4 2025, $3.0 million in Q3 2025, and $4.2 million in Q2 2025.